Heidelberg Pharma AG Long Term Debt

Heidelberg Pharma AG (HPHA.DE) currently reports a long-term debt of $46K as of May 2026. That compares with $38M in the prior-year period — down 99.9% year over year. Use the charts on this page to explore Heidelberg Pharma AG's long-term debt history and peer comparisons.

Heidelberg Pharma AG's long-term debt decreased from $38M to $46K — a 99.9% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Heidelberg Pharma AG reported $46K in long-term debt as of May 2026. That compares with $38M in the prior-year period — down 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $46K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Heidelberg Pharma AG, and consider following HPHA.DE for alerts when major investors trade the stock.

Heidelberg Pharma AG is classified in the Healthcare sector. On long-term debt, it currently shows $46K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HPHA.DE with unrelated industries.